Description
Trichomoniasis, also called “trich”, is the most common non-viral sexually transmitted infection (STI). Its etiological agent is the protozoan parasite Trichomonas vaginalis, against which first-line antiparasitics usually work. However, resistance is on the rise. Trich has traditionally been considered a nuisance infection, with many (particularly AMAB patients) being asymptomatic. But research in recent years has begun to unravel correlations of trichomonal infections with a myriad of comorbitidies, including infertility, cancers, the pathogenesis of AIDS, and pelvic inflammatory disease (PID). Between the rise of drug resistance and the incidence of these comorbidities, new treatments are needed. In this work, we are reviewing clinical and preclinical reports of essential oils in the treatment of trich or in the inhibition of Trichomonas growth.
Disciplines
Clinical Trials | Health and Medical Administration | Health and Physical Education | Health Services Research | Medical Education | Medical Sciences | Medicine and Health Sciences | Nursing | Primary Care | Scholarship of Teaching and Learning | Teacher Education and Professional Development
Document Type
Event
Recommended Citation
Hartwell, Claire; Arslanian, Melanie; and Haubrich, Brad, "Pharmacognosy and Trichomoniasis: A Scoping Review Protocol" (2024). Annual Research Symposium. 3.
https://ecommons.roseman.edu/researchsymposium/2024/clinical_case_reports/3
Included in
Clinical Trials Commons, Health and Medical Administration Commons, Health and Physical Education Commons, Health Services Research Commons, Medical Education Commons, Medical Sciences Commons, Nursing Commons, Primary Care Commons, Scholarship of Teaching and Learning Commons, Teacher Education and Professional Development Commons
Pharmacognosy and Trichomoniasis: A Scoping Review Protocol
Trichomoniasis, also called “trich”, is the most common non-viral sexually transmitted infection (STI). Its etiological agent is the protozoan parasite Trichomonas vaginalis, against which first-line antiparasitics usually work. However, resistance is on the rise. Trich has traditionally been considered a nuisance infection, with many (particularly AMAB patients) being asymptomatic. But research in recent years has begun to unravel correlations of trichomonal infections with a myriad of comorbitidies, including infertility, cancers, the pathogenesis of AIDS, and pelvic inflammatory disease (PID). Between the rise of drug resistance and the incidence of these comorbidities, new treatments are needed. In this work, we are reviewing clinical and preclinical reports of essential oils in the treatment of trich or in the inhibition of Trichomonas growth.
